Evidence map›Paper›PMID 41187790›Full record

ArticleDrug testing and analysis2026

Toxic Tear Gas 2-Chloroacetophenone (CN) Forms Adducts With Endogenous Plasma Thiols In Vitro Valuable as Biomarkers of Exposure.

Paula Helena Sieber, Dirk Steinritz, Franz Worek, Harald John

Abstract read
In one paragraph

Article in Drug testing and analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paula Helena SieberBundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.ORCID https://orcid.org/0009-0000-1977-9091
Dirk SteinritzBundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
Franz WorekBundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
Harald JohnBundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.ORCID https://orcid.org/0000-0002-7126-6709

Funding

German Research Foundation GRK2338
6 · The paper itself

Abstract

As the tear gas of the highest toxicity, 2-chloroacetophenone (CN) poses a potential threat for exposed individuals. Several fatality cases following exposure to CN are documented, but an unambiguous identification of CN exposure is still missing. Thus, we herein present the identification of in vitro reaction products between CN and endogenous molecules useful as biomarkers. After incubation of human plasma with CN, diverse acetophenone (AcPhen)-adducts were formed with the small molecule thiols homocysteine (HCys), glutathione (GSH), and cystine (Cys-Cys). All adducts were detected by microbore liquid chromatography-electrospray ionization high-resolution tandem mass spectrometry (μLC-ESI MS/HRMS) working in the parallel reaction monitoring (PRM) mode and were characterized as potential biomarkers of CN exposure. Time- and concentration-dependent adduct formations were investigated, and the stability of AcPhen-adducts in plasma during 4 freeze-and-thaw cycles and in the autosampler was tested. The limit of identification (LOI) of identified AcPhen-adducts in vitro was found at about 6 μM (concentration of CN in plasma) but showed quite limited in vitro stability. The AcPhen-adducts herein presented might be beneficial for future studies addressing CN exposure in vivo.

Indexed as

AcetophenonesSulfhydryl CompoundsBiomarkersChromatography, LiquidGlutathioneHomocysteineHumansLimit of DetectionSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryAcetophenonesBiomarkersGlutathioneHomocysteineSulfhydryl Compoundsacetophenone‐adductbiomarkers of exposurebiomedical verificationhigh‐resolution tandem mass spectrometryOrbitrap analysis

Identifiers

PMID41187790
PMCPMC12796557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.